A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/07/2006	US7132117 Sexual dysfunction, male infertility; root extract; topical application
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	US7132109 Administering to the subject a vaccine comprising component against which an immune response is desired to be induced; administering to the subject a heat shock protein preparation which does not display immunogenicity of the component
11/07/2006	US7132107 For prophylaxis and therapy of prevention and pneumococcal infection
11/07/2006	US7132102 Bacteriocin isolated from Lactobacillus salivarius deposited with United States Department of Agricultural, Agricultural Research Service Patent Culture Collection as Accession Number NRRL-B30514; used for reducing the levels of colonization by a target bacteria in animals, especially poultry
11/07/2006	US7132098 Administering a glycosidase that degrades chondroitin sulfate or hyaluronic acid to an intervertebral disk having a nucleus pulposus and an annulus fibrosus, adminstering a growth factor within 24 hours to stimulate formation of a matrix
11/07/2006	US7131994 Muscle-based grafts/implants
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2277824C Dosage composition for nasal delivery and method of use of the same
11/07/2006	CA2183856C Tcf mutant
11/07/2006	CA2139353C Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder
11/07/2006	CA2128511C Monomeric and dimeric antibody-fragment fusion proteins
11/07/2006	CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
11/05/2006	WO2006103110A1 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
11/02/2006	WO2006116746A2 Methods and compositions for using alveolar macrophage phospholipase a2
11/02/2006	WO2006116737A2 Compounds and methods for modulating cadherin-mediated processes
11/02/2006	WO2006116546A1 Surface-modified microparticles and methods of forming and using the same
11/02/2006	WO2006116524A1 Compositions and methods for promoting hemostasis and other physiological activities
11/02/2006	WO2006116452A1 Nutritional composition comprising hyaluronic acid and superoxide dismutase and methods of making and using same
11/02/2006	WO2006116410A2 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
11/02/2006	WO2006116302A2 High-potency botulinum toxin formulations
11/02/2006	WO2006116272A1 Compositions and methods for binding agglomeration proteins
11/02/2006	WO2006116181A2 Regulatory t cell mediator proteins and uses thereof
11/02/2006	WO2006116034A1 N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertility
11/02/2006	WO2006115800A2 Enhanced wound healing utilizing an anti-her2 antibody coupled to a tnf alpha
11/02/2006	WO2006115776A1 Rate control during af using cellular intervention to modulate av node
11/02/2006	WO2006115448A1 Treatment of inclusion body myositis
11/02/2006	WO2006115295A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
11/02/2006	WO2006115274A1 Myeloerythroid progenitor differentiation inducer
11/02/2006	WO2006115137A1 2-aminobenzimidazole derivative and use of the same for medical purposes
11/02/2006	WO2006115135A1 Therapeutic agent for irritable bowel syndrome
11/02/2006	WO2006115026A1 Humanin receptor or humanin-like polypeptide receptor
11/02/2006	WO2006114799A1 Synthetic peptides for the diagnosis and therapy of berillium granulomatous disease
11/02/2006	WO2006114788A1 Kinesin polypeptides, polynucleotides encoding same and compositions and methods of using same
11/02/2006	WO2006114691A1 Erythrocytes containing arginine deiminase
11/02/2006	WO2006114657A1 Lys-thr dipeptides and their use
11/02/2006	WO2006114478A1 Diagnostic and therapeutic agents
11/02/2006	WO2006114448A2 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
11/02/2006	WO2006114441A1 Blood pressure lowering protein hydrolysates
11/02/2006	WO2006114439A2 Novel nutraceutical compositions
11/02/2006	WO2006114324A1 Compounds comprising cyclized somatostatin receptor binding peptides
11/02/2006	WO2006114322A1 Use of tlr and/or nod2 ligands for producing a medicament for treating a disease of the central nervous system
11/02/2006	WO2006114308A2 Carrier for targeting nerve cells
11/02/2006	WO2006114195A1 Compositions comprising tripeptides inhibiting ace
11/02/2006	WO2006114194A1 Peptides having a health benefit and compositions comprising them
11/02/2006	WO2006114193A1 Peptides having an ace inhibiting effect
11/02/2006	WO2006114192A1 Peptides having an ace inhibiting effect
11/02/2006	WO2006114096A1 Pyrrolidinone dipeptide analogs and use thereof as artificial sweeteners
11/02/2006	WO2006113993A1 MATRIX METALLOPROTEINASE INHIBITORS OF TGFß -INDUCED SUBCAPSULAR CATARACT FORMATION
11/02/2006	WO2006091506A3 Neuropeptide y4 receptor agonists
11/02/2006	WO2006089150A3 Antiangiogenic agents with aldesleukin
11/02/2006	WO2006087756A3 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
11/02/2006	WO2006076902A3 Recombinant expression of proteins in a disulfide-bridged, two-chain form
11/02/2006	WO2006075350A3 Use of the pof1 gene product for cosmetic and/or therapeutic use of skin associated disorders
11/02/2006	WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006	WO2006072613A3 Preparation comprising microparticles of an insoluble polysaccharide resin with a biopolymeric active ingredient and method for production thereof
11/02/2006	WO2006059227B1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery
11/02/2006	WO2006051110A3 Stable formulations of insulinoptropic peptides
11/02/2006	WO2006039663A3 Methods for the administration of iloperidone
11/02/2006	WO2006034373A3 Variants and chemically-modified variants of phenylalanine ammonia-lyase
11/02/2006	WO2006032909A3 Pka ii anchoring disruption polypeptide
11/02/2006	WO2006025718A3 Immunogen and antivenom against violin spider venom
11/02/2006	WO2005110493A8 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
11/02/2006	WO2005095442A8 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
11/02/2006	WO2005087258A8 Use of botulinum toxin for preparing a drug for preventing hair growth
11/02/2006	WO2005060479A3 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
11/02/2006	WO2005049638A3 Amniotic-derived peptide and uses thereof
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248602 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247429 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
11/02/2006	US20060247428 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
11/02/2006	US20060247426 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
11/02/2006	US20060247423 Hemoglobin conjugate and the preparation method and its use
11/02/2006	US20060247422 Chemically modified G-CSF
11/02/2006	US20060247420 Immune cell recptor ligand and immune cell receptor
11/02/2006	US20060247417 Labelling peptides with hydrazide/hydrazine moieties
11/02/2006	US20060247416 HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
11/02/2006	US20060247315 Method of treating intestinal disorders with citrulline
11/02/2006	US20060247310 Body temperature elevating agents
11/02/2006	US20060247252 Augmented cognitive training
11/02/2006	US20060247201 using an exogenously-derived colony-stimulating factor 5 hyaluronidase (CSF5hyaluronidase) for treatment of myelosuppression as may occur after irradiation, chemotherapy or other diseases where an increase in leukocyte levels may be beneficial
11/02/2006	US20060247200 Methods and uses of leukotriene B4 hydroxylases to treat diseases
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247196 Yeast genes that affect viral replication
11/02/2006	US20060247192 Control of apoptosis
11/02/2006	US20060247191 Chimeric cytoplasmic signalling molecules
11/02/2006	US20060247178 Mitotic kinesin inhibitors and methods of use thereof
11/02/2006	US20060247177 Gonadotropin releasing hormone analogues conjugates with steroid hormones
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247175 Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient
11/02/2006	US20060247174 Use of a peptide
11/02/2006	US20060247173 Alpha-conotoxin peptides
11/02/2006	US20060247172 Methods and compositions for control of fetal growth via modulation of relaxin
11/02/2006	US20060247171 Use of a peptide
11/02/2006	US20060247170 Modified growth hormones
11/02/2006	US20060247169 Anti-tumor agent
11/02/2006	US20060247168 Use of ADNF polypeptides for treating peripheral neurotoxicity

1 ... 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 ... 3163